Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

69.23
+3.635.53%
Post-market: 69.700.4700+0.68%19:58 EDT
Volume:13.47M
Turnover:931.59M
Market Cap:307.32B
PE:22.04
High:69.86
Open:69.75
Low:68.53
Close:65.60
Loading ...

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out

Dow Jones
·
14 Apr

Pfizer Ends Development Of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
12 Apr

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading

MT Newswires Live
·
11 Apr

Here's Why Novo Nordisk (NVO) is a Strong Value Stock

Zacks
·
11 Apr

Novo Remade Denmark. Then Came the Stock Selloff. -- Barrons.com

Dow Jones
·
11 Apr

Novo Resources Unveils New Investor Presentation Highlighting Growth Strategy

TIPRANKS
·
10 Apr

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
10 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Motley Fool
·
09 Apr

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks
·
09 Apr

Trump Trade: Trump claims ‘no inflation,’ Medicare won’t cover obesity drugs

TipRanks
·
08 Apr

LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?

Zacks
·
08 Apr

Market Chatter: Novo Nordisk to Invest $1.09 Billion in Brazil Production Expansion

MT Newswires Live
·
08 Apr

Novo Nordisk's $1B Power Play: Can Brazil Make or Break the Ozempic Empire?

GuruFocus
·
08 Apr

Novo Nordisk (NVO) Will Invest $1.09B to Increase Production at Brazilian Factory

TIPRANKS
·
08 Apr

Novo Nordisk Considers Early Launch of Weight-Loss Jab Wegovy in India, Reuters Says, Citing Sources

Dow Jones
·
08 Apr

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
08 Apr

NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare

Zacks
·
07 Apr